-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
The British government vaccine consultant said that low-dose COVID-19 vaccine should be provided to disadvantaged primary school students
COVID-19
A low-dose COVID-19 vaccine has recently been approved for use in the UK and is expected to be used in vulnerable children , but the government has not yet decided to vaccinate all children aged 5 to 11
child
Pfizer BioNTech's low-dose vaccine is one-third of the adult dose, and immunizations should be separated by eight weeks
immunity
MHRA CEO Dr.
Currently, the vaccine is expected to be limited to children who are considered vulnerable due to diseases such as heart and lung diseases, cancer and severe neurological dysfunction
Currently, the vaccine is expected to be limited to children who are considered vulnerable due to diseases such as heart and lung diseases, cancer and severe neurological dysfunction
In order to slow the rapid spread of Omicron, the UK NHS is currently giving priority to providing booster doses for adults
Original source:
Original source:https:// href="https://" target="_blank" rel="noopener">https:// https://